CoChat

Sprouty-related proteins with EVH1 domain (SPRED2) prevents high-glucose induced endothelial–mesenchymal transition and endothelial injury by suppressing MAPK activation

Open access
Liu, Tian, Zhao, Jing, Lin, Chengmin · 2022 · Bioengineered

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

Abstract

Diabetic retinopathy (DR) is a common complication of diabetes, and the leading cause of blindness in adults. Sprouty-related proteins with EVH1 domain (SPRED2) play an important role in diabetes and are closely related to the lens and eye morphogenesis. This study attempted to investigate the role and related mechanism of SPRED2 in DR. DR rat model was established by administration streptozocin. Human retinal endothelial cells (HRECs) were treated with high glucose (HG) to mimic DR. The results showed that SPRED2 expression was decreased in the retinal tissues of DR rats and HG-treated HRECs. MTT assay and flow cytometry data showed that SPRED2 overexpression reduced cell viability of HG-treated HRECs. SPRED2 overexpression enhanced Caspase-3 activity and promoted apoptosis of HG-treated HRECs. Furthermore, the expressions of endothelial cell markers CD31 and E-cad were down-regulated, whereas the expressions of mesenchymal cell markers FSP1, SM22, and α-SMA were up-regulated in the HG-treated HRECs. SPRED2 overexpression reversed HG-induced endothelial-mesenchymal transition in HRECs. The expressions of tight junction components claudin 3, occludin, and ZO-1 were increased in HG-treated HRECs following SPRED2 up-regulation. In addition, SPRED2 overexpression downregulated the expression of p-ERK1/2, p-p38, and p-JNK in the HG-treated HRECs. In conclusion, this study demonstrated that SPRED2 overexpression repressed endothelial-mesenchymal transition and endothelial injury in HG-treated HRECs by suppressing MAPK signaling pathway. These findings suggested that SPRED2 may be a novel potential therapeutic target implicated in DR progression.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/21655979.2022.2086351This paper is marked retracted.

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Figures

Graphical abstract
Graphical abstract CC BY-NC · PubMed Central
Figure 1. SPRED2 expression was decreased in the DR rats and HG-treated HRECs. DR rat model was constructed by injection of STZ. Sham rats were injected with SSC as control. (a- and b) The overexpression efficiency of SPRED2 was confirmed through qRT-PCR and western blot. (c) The retina changes were assessed through HE staining. (d) The blood glucose of DR and Sham rats was detected. The mRNA and protein expression of SPRED2 in the retinal tissues of DR and Sham rats was assessed by qRT-PCR (e) and WB (f). HRECs were treated with 25 mmol/L glucose (HG) or 5 mmol/L glucose (Control) for 24 h. The mRNA and protein expression of SPRED2 in the HRECs was examined by qRT-PCR (g) and WB (h). ***P < 0.001 vs. Control.
Figure 1. SPRED2 expression was decreased in the DR rats and HG-treated HRECs. DR rat model was constructed by injection of STZ. Sham rats were injected with SSC as control. (a- and b) The overexpression efficiency of SPRED2 was confirmed through qRT-PCR and western blot. (c) The retina changes were assessed through HE staining. (d) The blood glucose of DR and Sham rats was detected. The mRNA and protein expression of SPRED2 in the retinal tissues of DR and Sham rats was assessed by qRT-PCR (e) and WB (f). HRECs were treated with 25 mmol/L glucose (HG) or 5 mmol/L glucose (Control) for 24 h. The mRNA and protein expression of SPRED2 in the HRECs was examined by qRT-PCR (g) and WB (h). ***P < 0.001 vs. Control.CC BY-NC · PubMed Central
Figure 2. SPRED2 overexpression promoted cell viability and repressed apoptosis of HG-treated HRECs. HRECs were transfected with pCEP4-SPRED2 or pCEP4-NC, followed by 25 mmol/L glucose (HG) treatment for 24 h. (a) The protein expression of SPRED2 in the HRECs was examined by WB. (b) Cell viability of HRECs was detected by MTT assay. (c- and d) Cell apoptosis of HRECs was measured by flow cytometry. (e) Caspase-3 activity of HRECs was detected. ###P < 0.001 vs. Control; @P < 0.05, @@P < 0.01, @@@P < 0.001 vs. HG + NC.
Figure 2. SPRED2 overexpression promoted cell viability and repressed apoptosis of HG-treated HRECs. HRECs were transfected with pCEP4-SPRED2 or pCEP4-NC, followed by 25 mmol/L glucose (HG) treatment for 24 h. (a) The protein expression of SPRED2 in the HRECs was examined by WB. (b) Cell viability of HRECs was detected by MTT assay. (c- and d) Cell apoptosis of HRECs was measured by flow cytometry. (e) Caspase-3 activity of HRECs was detected. ###P < 0.001 vs. Control; @P < 0.05, @@P < 0.01, @@@P < 0.001 vs. HG + NC.CC BY-NC · PubMed Central
Figure 3. SPRED2 overexpression inhibited EndMT of HG-treated HRECs. HRECs were transfected with pCEP4-SPRED2 or pCEP4-NC, followed by 25 mmol/L glucose (HG) treatment for 24 h. (a) The expression of CD31, E-cad, FSP1, SM22, and α-SMA in HRECs was assessed by WB. (b) IF staining was performed to detect the expression of E-cad and α-SMA in HRECs. ###P < 0.001 vs. Control; @P < 0.05, @@P < 0.01 vs. HG + NC.
Figure 3. SPRED2 overexpression inhibited EndMT of HG-treated HRECs. HRECs were transfected with pCEP4-SPRED2 or pCEP4-NC, followed by 25 mmol/L glucose (HG) treatment for 24 h. (a) The expression of CD31, E-cad, FSP1, SM22, and α-SMA in HRECs was assessed by WB. (b) IF staining was performed to detect the expression of E-cad and α-SMA in HRECs. ###P < 0.001 vs. Control; @P < 0.05, @@P < 0.01 vs. HG + NC.CC BY-NC · PubMed Central
Figure 4. SPRED2 overexpression inhibited BRB damage. HRECs were transfected with pCEP4-SPRED2 or pCEP4-NC, followed by 25 mmol/L glucose (HG) treatment for 24 h. The expression of claudin 3, occludin, and ZO-1 in HRECs was assessed by WB. ###P < 0.001 vs. Control; @P < 0.05 vs. HG + NC.
Figure 4. SPRED2 overexpression inhibited BRB damage. HRECs were transfected with pCEP4-SPRED2 or pCEP4-NC, followed by 25 mmol/L glucose (HG) treatment for 24 h. The expression of claudin 3, occludin, and ZO-1 in HRECs was assessed by WB. ###P < 0.001 vs. Control; @P < 0.05 vs. HG + NC.CC BY-NC · PubMed Central
Figure 5. SPRED2 overexpression repressed MAPK signaling pathway. HRECs were transfected with pCEP4-SPRED2 or pCEP4-NC, followed by 25 mmol/L glucose (HG) treatment for 24 h. The expression of p-ERK1/2, ERK1/2, p-p38, p38, p-JNK, and JNK in HRECs was assessed by WB. ###P < 0.001 vs. Control; @@P < 0.01, @@@P < 0.001 vs. HG + NC.
Figure 5. SPRED2 overexpression repressed MAPK signaling pathway. HRECs were transfected with pCEP4-SPRED2 or pCEP4-NC, followed by 25 mmol/L glucose (HG) treatment for 24 h. The expression of p-ERK1/2, ERK1/2, p-p38, p38, p-JNK, and JNK in HRECs was assessed by WB. ###P < 0.001 vs. Control; @@P < 0.01, @@@P < 0.001 vs. HG + NC.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

2 retracted

Show all 43 references

Research works printed but not linked: 1

  1. 10.1096/fj.201802614rrr · DOI

Cited by

See all 14

Metadata

Authors
Liu, T., Zhao, J., & Lin, C.
Affiliations
  • First People’s Hospital of Jingmen (CN)
  • Wenzhou Hospital of Traditional Chinese Medicine (CN)
Corresponding author
Lin, Chengmin
Venue
Bioengineered
Published
2022-05-02
Volume
13
Issue
5
Pages
13882-13892
ISSN
  • 2165-5979 (ISSN-L)
  • 2165-5987
OpenAlex
W4283020754
Cited by
12
References
43
Citations by year
2026: 2 · 2025: 4 · 2024: 2 · 2023: 4
FWCI
2.23
Type
journal article
Language
en
Status
Retracted
Open access
Licence
Locations
  • Bioengineered (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • Figshare (submittedVersion, cc-by)
  • Figshare (cc-by)
Funders
reported
Topics
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
Keywords
SPRED2, diabetic retinopathy, endothelial-to-mesenchymal transition, high glucose, retinal endothelial cells, MAPK signaling, ERK1/2, p38 MAPK, JNK, endothelial injury, apoptosis, tight junctions, streptozotocin-induced diabetes, therapeutic target
MeSH terms
Animals, Diabetic Retinopathy, Glucose, Retina, Signal Transduction, Endothelial Cells, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Sprouty-related proteins with EVH1 domain (SPRED2) prevents high-glucose induced endothelial–mesenchymal transition and endothelial injury by suppressing MAPK activation. https://app.cochat.ai/papers/10.1080/21655979.2022.2086351
The paper
Liu, T., Zhao, J., & Lin, C. (2022). Sprouty-related proteins with EVH1 domain (SPRED2) prevents high-glucose induced endothelial–mesenchymal transition and endothelial injury by suppressing MAPK activation. Bioengineered. https://doi.org/10.1080/21655979.2022.2086351

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.